To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Euphraxia Pharmaceuticals to secure debt funding from SVB
Victoria, British Columbia-based biotechnology company Eupraxia Pharmaceuticals has entered into a C$10 million convertible debt agreement.
